Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: CSR

Citadel and Citadel Securities and the Bill & Melinda Gates Foundation to Increase the Supply of Medical Oxygen in India


CHICAGO, May 7, 2021 /PRNewswire/ -- The partners of Citadel and Citadel Securities today announced new commitments totaling $5.5 million to increase the supply of medical oxygen in India. As the nation experiences a devastating surge in COVID-19 cases, the demand for medical oxygen has risen to unprecedented levels.

The grants from Citadel and Citadel Securities, the Bill & Melinda Gates Foundation and Gates Philanthropy Partners have been directed to the global health nonprofit PATH. They will be used to support near-term, critical needs while also building infrastructure that will be beneficial far beyond the current pandemic.

"Our hearts go out to the people of India as they battle this devastating surge in COVID-19," said Ken Griffin, Founder and CEO of Citadel. "We are proud to continue accelerating impactful solutions to address urgent needs during the pandemic."

"Lack of access to medical oxygen is one of the defining health challenges of our age," said Chris Elias, President of Global Development at the Bill & Melinda Gates Foundation. "As we are now seeing in India, the consequences can be dire, which is why we must come together with others to help address this important issue both during the current crisis and beyond."

Citadel and the Gates Foundation have partnered with PATH, an organization that works with governments, businesses and other organizations to solve the world's most pressing health challenges. PATH is currently coordinating with multiple state governments in India to address the oxygen shortage, while also providing the technical expertise required to set up oxygen-generating plants at healthcare facilities. 

"PATH is responding to the urgent COVID-19 crisis in India and globally, including monitoring medical oxygen demand, increasing access to vaccines and strengthening disease surveillance," said Nikolaj Gilbert, President and CEO of PATH. "Our impact hinges on the generosity of our partners. We are grateful for the support Citadel and the Bill & Melinda Gates Foundation have shown so that we can continue our lifesaving work where it is needed most."

About Citadel

Citadel is one of the world's leading alternative investment managers. Citadel manages the capital of prominent investors from around the world, including retirement programs, endowments and foundations, and sovereign wealth funds. For more information, visit www.Citadel.com.

About Citadel Securities

Citadel Securities is a leading global market maker, delivering a broad array of fixed income and equity products to banks, broker-dealers, government agencies, corporations, insurers, and sovereign wealth funds. For more information, visit www.CitadelSecurities.com.

Media Contacts
Zia Ahmed
[email protected]

 

SOURCE Citadel; Citadel Securities


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: